+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Testosterone Replacement Therapy Market 2024-2028

  • PDF Icon

    Report

  • 167 Pages
  • November 2023
  • Region: Global
  • TechNavio
  • ID: 5769576
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The testosterone replacement therapy market is forecasted to grow by USD 497.67 million during 2023-2028, accelerating at a CAGR of 3.7% during the forecast period. The report on the testosterone replacement therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising initiatives to increase awareness about hypogonadism among people, rise in prevalence of chronic diseases, and increasing aging population and postmenopausal women.

The testosterone replacement therapy market is segmented as below:

By Distribution Channel

  • Hospitals
  • Retail
  • Online

By Product

  • Injectables
  • Topicals
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rise in novel therapeutic approaches for testosterone replacement therapy as one of the prime reasons driving the testosterone replacement therapy market growth during the next few years. Also, increasing patient assistance programs and growing advancements in testosterone replacement therapy market will lead to sizable demand in the market.

The report on the testosterone replacement therapy market covers the following areas:

  • Testosterone replacement therapy market sizing
  • Testosterone replacement therapy market forecast
  • Testosterone replacement therapy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading testosterone replacement therapy market vendors that include AbbVie Inc., Acerus Pharmaceuticals Corp., Actiza Pharmaceutical Pvt. Ltd., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, Cipla Ltd., Eli Lilly and Co., Endo International Plc, Ferring BV, Halozyme Therapeutics Inc., Insud Pharma S.L, Lupin Ltd., Marius Pharmaceuticals, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Acrux Ltd., Alvogen Iceland ehf, and Sawai Pharmaceutical Co. Ltd.. Also, the testosterone replacement therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global testosterone replacement therapy market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global testosterone replacement therapy market 2018 - 2022 ($ million)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospitals - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 Retail - Market size and forecast 2023-2028
Exhibit 38: Chart on Retail - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Retail - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Retail - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Retail - Year-over-year growth 2023-2028 (%)
6.5 Online - Market size and forecast 2023-2028
Exhibit 42: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Online - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ million)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Injectables - Market size and forecast 2023-2028
Exhibit 52: Chart on Injectables - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Injectables - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
7.4 Topicals - Market size and forecast 2023-2028
Exhibit 56: Chart on Topicals - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Topicals - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Topicals - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Topicals - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Product
Exhibit 64: Market opportunity by Product ($ million)
Exhibit 65: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
12.4 Acerus Pharmaceuticals Corp.
Exhibit 119: Acerus Pharmaceuticals Corp. - Overview
Exhibit 120: Acerus Pharmaceuticals Corp. - Product / Service
Exhibit 121: Acerus Pharmaceuticals Corp. - Key offerings
12.5 Alembic Pharmaceuticals Ltd.
Exhibit 122: Alembic Pharmaceuticals Ltd. - Overview
Exhibit 123: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibit 124: Alembic Pharmaceuticals Ltd. - Key offerings
12.6 Amneal Pharmaceuticals Inc.
Exhibit 125: Amneal Pharmaceuticals Inc. - Overview
Exhibit 126: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 127: Amneal Pharmaceuticals Inc. - Key news
Exhibit 128: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 129: Amneal Pharmaceuticals Inc. - Segment focus
12.7 Bausch Health Companies Inc.
Exhibit 130: Bausch Health Companies Inc. - Overview
Exhibit 131: Bausch Health Companies Inc. - Business segments
Exhibit 132: Bausch Health Companies Inc. - Key news
Exhibit 133: Bausch Health Companies Inc. - Key offerings
Exhibit 134: Bausch Health Companies Inc. - Segment focus
12.8 Bayer AG
Exhibit 135: Bayer AG - Overview
Exhibit 136: Bayer AG - Business segments
Exhibit 137: Bayer AG - Key news
Exhibit 138: Bayer AG - Key offerings
Exhibit 139: Bayer AG - Segment focus
12.9 Cipla Ltd.
Exhibit 140: Cipla Ltd. - Overview
Exhibit 141: Cipla Ltd. - Business segments
Exhibit 142: Cipla Ltd. - Key news
Exhibit 143: Cipla Ltd. - Key offerings
Exhibit 144: Cipla Ltd. - Segment focus
12.10 Eli Lilly and Co.
Exhibit 145: Eli Lilly and Co. - Overview
Exhibit 146: Eli Lilly and Co. - Product / Service
Exhibit 147: Eli Lilly and Co. - Key news
Exhibit 148: Eli Lilly and Co. - Key offerings
12.11 Endo International Plc
Exhibit 149: Endo International Plc - Overview
Exhibit 150: Endo International Plc - Business segments
Exhibit 151: Endo International Plc - Key news
Exhibit 152: Endo International Plc - Key offerings
Exhibit 153: Endo International Plc - Segment focus
12.12 Ferring BV
Exhibit 154: Ferring BV - Overview
Exhibit 155: Ferring BV - Product / Service
Exhibit 156: Ferring BV - Key offerings
12.13 Halozyme Therapeutics Inc.
Exhibit 157: Halozyme Therapeutics Inc. - Overview
Exhibit 158: Halozyme Therapeutics Inc. - Product / Service
Exhibit 159: Halozyme Therapeutics Inc. - Key offerings
12.14 Marius Pharmaceuticals
Exhibit 160: Marius Pharmaceuticals - Overview
Exhibit 161: Marius Pharmaceuticals - Product / Service
Exhibit 162: Marius Pharmaceuticals - Key offerings
12.15 Pfizer Inc.
Exhibit 163: Pfizer Inc. - Overview
Exhibit 164: Pfizer Inc. - Product / Service
Exhibit 165: Pfizer Inc. - Key news
Exhibit 166: Pfizer Inc. - Key offerings
12.16 Sawai Pharmaceutical Co. Ltd.
Exhibit 167: Sawai Pharmaceutical Co. Ltd. - Overview
Exhibit 168: Sawai Pharmaceutical Co. Ltd. - Business segments
Exhibit 169: Sawai Pharmaceutical Co. Ltd. - Key offerings
Exhibit 170: Sawai Pharmaceutical Co. Ltd. - Segment focus
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 171: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 172: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 173: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 175: Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 176: Inclusions checklist
Exhibit 177: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 178: Currency conversion rates for US$
13.4 Research methodology
Exhibit 179: Research methodology
Exhibit 180: Validation techniques employed for market sizing
Exhibit 181: Information sources
13.5 List of abbreviations
Exhibit 182: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Product
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 18: Historic Market Size - Data Table on global testosterone replacement therapy market 2018 - 2022 ($ million)
Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 38: Chart on Retail - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Retail - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Retail - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Retail - Year-over-year growth 2023-2028 (%)
Exhibit 42: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibit 46: Market opportunity by Distribution Channel ($ million)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
Exhibit 52: Chart on Injectables - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Injectables - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
Exhibit 56: Chart on Topicals - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Topicals - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Topicals - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Topicals - Year-over-year growth 2023-2028 (%)
Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibit 64: Market opportunity by Product ($ million)
Exhibit 65: Data Table on Market opportunity by Product ($ million)
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
Exhibit 111: Overview on factors of disruption
Exhibit 112: Impact of key risks on business
Exhibit 113: Vendors covered
Exhibit 114: Matrix on vendor position and classification
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
Exhibit 119: Acerus Pharmaceuticals Corp. - Overview
Exhibit 120: Acerus Pharmaceuticals Corp. - Product / Service
Exhibit 121: Acerus Pharmaceuticals Corp. - Key offerings
Exhibit 122: Alembic Pharmaceuticals Ltd. - Overview
Exhibit 123: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibit 124: Alembic Pharmaceuticals Ltd. - Key offerings
Exhibit 125: Amneal Pharmaceuticals Inc. - Overview
Exhibit 126: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 127: Amneal Pharmaceuticals Inc. - Key news
Exhibit 128: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 129: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 130: Bausch Health Companies Inc. - Overview
Exhibit 131: Bausch Health Companies Inc. - Business segments
Exhibit 132: Bausch Health Companies Inc. - Key news
Exhibit 133: Bausch Health Companies Inc. - Key offerings
Exhibit 134: Bausch Health Companies Inc. - Segment focus
Exhibit 135: Bayer AG - Overview
Exhibit 136: Bayer AG - Business segments
Exhibit 137: Bayer AG - Key news
Exhibit 138: Bayer AG - Key offerings
Exhibit 139: Bayer AG - Segment focus
Exhibit 140: Cipla Ltd. - Overview
Exhibit 141: Cipla Ltd. - Business segments
Exhibit 142: Cipla Ltd. - Key news
Exhibit 143: Cipla Ltd. - Key offerings
Exhibit 144: Cipla Ltd. - Segment focus
Exhibit 145: Eli Lilly and Co. - Overview
Exhibit 146: Eli Lilly and Co. - Product / Service
Exhibit 147: Eli Lilly and Co. - Key news
Exhibit 148: Eli Lilly and Co. - Key offerings
Exhibit 149: Endo International Plc - Overview
Exhibit 150: Endo International Plc - Business segments
Exhibit 151: Endo International Plc - Key news
Exhibit 152: Endo International Plc - Key offerings
Exhibit 153: Endo International Plc - Segment focus
Exhibit 154: Ferring BV - Overview
Exhibit 155: Ferring BV - Product / Service
Exhibit 156: Ferring BV - Key offerings
Exhibit 157: Halozyme Therapeutics Inc. - Overview
Exhibit 158: Halozyme Therapeutics Inc. - Product / Service
Exhibit 159: Halozyme Therapeutics Inc. - Key offerings
Exhibit 160: Marius Pharmaceuticals - Overview
Exhibit 161: Marius Pharmaceuticals - Product / Service
Exhibit 162: Marius Pharmaceuticals - Key offerings
Exhibit 163: Pfizer Inc. - Overview
Exhibit 164: Pfizer Inc. - Product / Service
Exhibit 165: Pfizer Inc. - Key news
Exhibit 166: Pfizer Inc. - Key offerings
Exhibit 167: Sawai Pharmaceutical Co. Ltd. - Overview
Exhibit 168: Sawai Pharmaceutical Co. Ltd. - Business segments
Exhibit 169: Sawai Pharmaceutical Co. Ltd. - Key offerings
Exhibit 170: Sawai Pharmaceutical Co. Ltd. - Segment focus
Exhibit 171: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 172: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 173: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 175: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibit 176: Inclusions checklist
Exhibit 177: Exclusions checklist
Exhibit 178: Currency conversion rates for US$
Exhibit 179: Research methodology
Exhibit 180: Validation techniques employed for market sizing
Exhibit 181: Information sources
Exhibit 182: List of abbreviations

Executive Summary

The analyst recognizes the following companies as the key players in the global testosterone replacement therapy market: AbbVie Inc., Acerus Pharmaceuticals Corp., Actiza Pharmaceutical Pvt. Ltd., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, Cipla Ltd., Eli Lilly and Co., Endo International Plc, Ferring BV, Halozyme Therapeutics Inc., Insud Pharma S.L, Lupin Ltd., Marius Pharmaceuticals, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Acrux Ltd., Alvogen Iceland ehf, and Sawai Pharmaceutical Co. Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rise in novel therapeutic approaches for testosterone replacement therapy.'

According to the report, one of the major drivers for this market is the rising initiatives to increase awareness about hypogonadism among people.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Acerus Pharmaceuticals Corp.
  • Actiza Pharmaceutical Pvt. Ltd.
  • Alembic Pharmaceuticals Ltd.
  • Amneal Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Ltd.
  • Eli Lilly and Co.
  • Endo International Plc
  • Ferring BV
  • Halozyme Therapeutics Inc.
  • Insud Pharma S.L
  • Lupin Ltd.
  • Marius Pharmaceuticals
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Acrux Ltd.
  • Alvogen Iceland ehf
  • Sawai Pharmaceutical Co. Ltd.

Related Topics

Related Reports

Testosterone Replacement Therapy Market Report by Product Type, Active Ingredients, End User, and Region 2024-2032 - Product Image

Testosterone Replacement Therapy Market Report by Product Type, Active Ingredients, End User, and Region 2024-2032

  • Report
  • 139 Pages
  • Global
From
Testosterone Replacement Therapy Global Market Report 2024 - Product Image

Testosterone Replacement Therapy Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Testosterone Replacement Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Testosterone Replacement Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 97 Pages
  • Global
From
Testosterone undecanoate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Testosterone undecanoate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 82 Pages
  • Global
From
Global Testosterone Replacement Therapy Market by Indication (Autoimmune Conditions, Genetic Disorders, Hypogonadism), Product Type (Buccal Adhesive, Gel or Creams, Implants), Drug Active Ingredient, Distribution Channel, End-Users - Forecast 2024-2030 - Product Image

Global Testosterone Replacement Therapy Market by Indication (Autoimmune Conditions, Genetic Disorders, Hypogonadism), Product Type (Buccal Adhesive, Gel or Creams, Implants), Drug Active Ingredient, Distribution Channel, End-Users - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.